Jubilant Pharma Singapore Announces Sale of 25.8% Stake in Sofie Biosciences and Subsequent Merger, with Potential $139.4 Million Proceeds Jubilant Pharma Singapore Announces Sale of 25.8% Stake in Sofie Biosciences and Subsequent Merger, with Potential $139.4 Million ProceedsBy bigbreakingwire on January 28, 2024
